SOX9 modulates the expression of key transcription factors required for heart valve development

Development (Cambridge)

Volumn 142, Issue 24, 2015, Pages 4340-4350

  Garside, Victoria C ^a,b   Cullum, Rebecca ^a   Alder, Olivia ^a   Lu, Daphne Y ^a   Werff, Ryan Vander ^b   Bilenky, Mikhail ^c   Zhao, Yongjun ^c   Jones, Steven J M ^b,c,d   Marra, Marco A ^b,c   Underhill, T Michael ^b   Hoodless, Pamela A ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d SIMON FRASER UNIVERSITY   (Canada)

Author keywords

ChIP Seq; Embryogenesis; Genome; Heart valves; Limb; Mouse; Proliferation; RNA Seq; SOX9; Transcription factor; Transcriptional networks

Indexed keywords

COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGEN TYPE 9; ELASTIN; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; PROTEIN P53; SCLEROPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MECOM; TRANSCRIPTION FACTOR PITX2; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX4; TRANSCRIPTION FACTOR SOX9; TRANSCRIPTION FACTOR TWIST 1; UNCLASSIFIED DRUG; DNA; PROTEIN BINDING;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; GENE EXPRESSION; HEART DEVELOPMENT; HEART VALVE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ANIMAL; BIOLOGICAL MODEL; CHROMATIN IMMUNOPRECIPITATION; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; LIMB; METABOLISM; MOUSE; PROMOTER REGION; TRANSCRIPTION INITIATION SITE;

ANIMALS; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DNA; EXTREMITIES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REGULATORY NETWORKS; HEART VALVES; MICE; MODELS, BIOLOGICAL; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, MESSENGER; SOX9 TRANSCRIPTION FACTOR; TRANSCRIPTION INITIATION SITE;

EID: 84951020134     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.125252     Document Type: Article

References (73)

1. Adam, R. C., Yang, H., Rockowitz, S., Larsen, S. B., Nikolova, M., Oristian, D. S., Polak, L., Kadaja, M., Asare, A., Zheng, D. et al. (2015). Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice. Nature 521, 366-370.
2. Akiyama, H., Chaboissier, M.-C., Martin, J. F., Schedl, A. and de Crombrugghe, B. (2002). The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16, 2813-2828.
3. Akiyama, H., Chaboissier, M.-C., Behringer, R. R., Rowitch, D. H., Schedl, A., Epstein, J. A. and de Crombrugghe, B. (2004). Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. Proc. Natl. Acad. Sci. USA 101, 6502-6507.
4. An, C.-I., Dong, Y. and Hagiwara, N. (2011). Genome-wide mapping of Sox6 binding sites in skeletal muscle reveals both direct and indirect regulation of muscle terminal differentiation by Sox6. BMC Dev. Biol. 11, 59.
5. Baker, A., Saltik, M., Lehrmann, H., Killisch, I., Mautner, V., Lamm, G., Christofori, G. and Cotten, M. (1997). Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery. Gene Ther. 4, 773-782.
6. Bard-Chapeau, E. A., Jeyakani, J., Kok, C. H., Muller, J., Chua, B. Q., Gunaratne, J., Batagov, A., Jenjaroenpun, P., Kuznetsov, V. A., Wei, C.-L. et al. (2012). Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors. Proc. Natl. Acad. Sci. USA 109, 2168-2173.
7. Bard-Chapeau, E. A., Szumska, D., Jacob, B., Chua, B. Q. L., Chatterjee, G. C., Zhang, Y.,Ward, J. M., Urun, F., Kinameri, E., Vincent, S. D. et al. (2014). Mice carrying a hypomorphic Evi1 allele are embryonic viable but exhibit severe congenital heart defects. PLoS ONE 9, e89397.
8. Bashur, L. A., Chen, D., Chen, Z., Liang, B., Pardi, R., Murakami, S. and Zhou, G. (2014). Loss of jab1 in osteochondral progenitor cells severely impairs embryonic limb development in mice. J. Cell. Physiol. 229, 1607-1617.
9. Bell, D. M., Leung, K. K., Wheatley, S. C., Ng, L. J., Zhou, S., Wing Ling, K., Har Sham, M., Koopman, P., Tam, P. P. L. and Cheah, K. S. E. (1997). SOX9 directly regulates the type-II collagen gene. Nat. Genet. 16, 174-178.
10. Benchabane, H. and Wrana, J. L. (2003). GATA- and Smad1-dependent enhancers in the Smad7 gene differentially interpret bone morphogenetic protein concentrations. Mol. Cell. Biol. 23, 6646-6661.
11. Bernard, P., Tang, P., Liu, S., Dewing, P., Harley, V. R. and Vilain, E. (2003). Dimerization of SOX9 is required for chondrogenesis, but not for sex determination. Hum. Mol. Genet. 12, 1755-1765.
12. Blankenberg, D., Von Kuster, G., Coraor, N., Ananda, G., Lazarus, R., Mangan, M., Nekrutenko, A. and Taylor, J. (2010). Galaxy: a web-based genome analysis tool for experimentalists. Curr. Protoc. Mol. Biol. 89, 19.10.1-19.10.21.
13. Boyd, K. E., Xiao, Y.-Y., Fan, K., Poholek, A., Copeland, N. G., Jenkins, N. A. and Perkins, A. S. (2006). Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR. Blood 107, 733-741.
14. Bracken, A. P., Pasini, D., Capra, M., Prosperini, E., Colli, E. and Helin, K. (2003). EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J. 22, 5323-5335.
15. Bridgewater, L. C., Lefebvre, V. and de Crombrugghe, B. (1998). Chondrocytespecific enhancer elements in the Col11a2 gene resemble the Col2a1 tissuespecific enhancer. J. Biol. Chem. 273, 14998-15006.
16. Cai, X., Zhang, W., Hu, J., Zhang, L., Sultana, N., Wu, B., Cai, W., Zhou, B. and Cai, C.-L. (2013). Tbx20 acts upstream of Wnt signaling to regulate endocardial cushion formation and valve remodeling during mouse cardiogenesis. Development 140, 3176-3187.
17. Chakraborty, S., Combs, M. D. and Yutzey, K. E. (2010a). Transcriptional regulation of heart valve progenitor cells. Pediatr. Cardiol. 31, 414-421.
18. Chakraborty, S., Wirrig, E. E., Hinton, R. B., Merrill, W. H., Spicer, D. B. and Yutzey, K. E. (2010b). Twist1 promotes heart valve cell proliferation and extracellular matrix gene expression during development in vivo and is expressed in human diseased aortic valves. Dev. Biol. 347, 167-179.
19. Chang, A. C. Y., Fu, Y., Garside, V. C., Niessen, K., Chang, L., Fuller, M., Setiadi, A., Smrz, J., Kyle, A., Minchinton, A. et al. (2011). Notch initiates the endothelial-to-mesenchymal transition in the atrioventricular canal through autocrine activation of soluble guanylyl cyclase. Dev. Cell 21, 288-300.
20. Chang, A. C. Y., Garside, V. C., Fournier, M., Smrz, J., Vrljicak, P., Umlandt, P., Fuller, M., Robertson, G., Zhao, Y., Tam, A. et al. (2014). A Notch-dependent transcriptional hierarchy promotes mesenchymal transdifferentiation in the cardiac cushion. Dev. Dyn. 243, 894-905.
21. Claret, F.-X., Hibi, M., Dhut, S., Toda, T. and Karin, M. (1996). A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383, 453-457.
22. de Vlaming, A., Sauls, K., Hajdu, Z., Visconti, R. P., Mehesz, A. N., Levine, R. A., Slaugenhaupt, S. A., Hagège, A., Chester, A. H., Markwald, R. R. et al. (2012). Atrioventricular valve development: new perspectives on an old theme. Differentiation 84, 103-116.
23. Eden, E., Navon, R., Steinfeld, I., Lipson, D. and Yakhini, Z. (2009). GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 10, 48.
24. Fejes, A. P., Robertson, G., Bilenky, M., Varhol, R., Bainbridge, M. and Jones, S. J. (2008). FindPeaks 3.1: a tool for identifying areas of enrichment from massively parallel short-read sequencing technology. Bioinformatics 24, 1729-1730.
25. Giono, L. E. and Manfredi, J. J. (2006). The p53 tumor suppressor participates in multiple cell cycle checkpoints. J. Cell Physiol. 209, 13-20.
26. Han, Y. and Lefebvre, V. (2008). L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol. Cell. Biol. 28, 4999-5013.
27. Holler, K. L., Hendershot, T. J., Troy, S. E., Vincentz, J. W., Firulli, A. B. and Howard, M. J. (2010). Targeted deletion of Hand2 in cardiac neural crest-derived cells influences cardiac gene expression and outflow tract development. Dev. Biol. 341, 291-304.
28. Hou, J., Charters, A. M., Lee, S. C., Zhao, Y., Wu, M. K., Jones, S. J. M., Marra, M. A. and Hoodless, P. A. (2007). A systematic screen for genes expressed in definitive endoderm by Serial Analysis of Gene Expression (SAGE). BMC Dev. Biol. 7, 92.
29. Hoyt, P. R., Bartholomew, C., Davis, A. J., Yutzey, K., Gamer, L.W., Potter, S. S., Ihle, J. N. and Mucenski, M. L. (1997). The Evil proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development. Mech. Dev. 65, 55-70.
30. Huang, W., Zhou, X., Lefebvre, V. and de Crombrugghe, B. (2000). Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer. Mol. Cell. Biol. 20, 4149-4158.
31. Hulin, A., Deroanne, C., Lambert, C., Defraigne, J.-O., Nusgens, B., Radermecker, M. and Colige, A. (2013). Emerging pathogenic mechanisms in human myxomatous mitral valve: lessons from past and novel data. Cardiovasc. Pathol. 22, 245-250.
32. Jain, V. and Sen, B. (2014). Campomelic dysplasia. J. Pediatr. Orthop. B 23, 485-488.
33. Jang, S.-W., Liu, X., Fu, H., Rees, H., Yepes, M., Levey, A. and Ye, K. (2009). Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell cycle and cell death in neurons. J. Biol. Chem. 284, 24512-24525.
34. Kadaja, M., Keyes, B. E., Lin, M., Pasolli, H. A., Genander, M., Polak, L., Stokes, N., Zheng, D. and Fuchs, E. (2014). SOX9: a stem cell transcriptional regulator of secreted niche signaling factors. Genes Dev. 28, 328-341.
35. Kamachi, Y. and Kondoh, H. (2013). Sox proteins: regulators of cell fate specification and differentiation. Development 140, 4129-4144.
36. Kang, P., Lee, H. K., Glasgow, S. M., Finley, M., Donti, T., Gaber, Z. B., Graham, B. H., Foster, A. E., Novitch, B. G., Gronostajski, R. M. et al. (2012). Sox9 and NFIA coordinate a transcriptional regulatory cascade during the initiation of gliogenesis. Neuron 74, 79-94.
37. Kelly, R. D. W. and Cowley, S. M. (2013). The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts. Biochem. Soc. Trans. 41, 741-749.
38. Kent,W. J., Sugnet, C.W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M. and Haussler, D. (2002). The human genome browser at UCSC. Genome Res. 12, 996-1006.
39. Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R. and Salzberg, S. L. (2013). TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36.
40. Kisanuki, Y. Y., Hammer, R. E., Miyazaki, J.-i.,Williams, S. C., Richardson, J. A. and Yanagisawa, M. (2001). Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 230, 230-242.
41. Lee, M. P. and Yutzey, K. E. (2011). Twist1 directly regulates genes that promote cell proliferation and migration in developing heart valves. PLoS ONE 6, e29758.
42. Lefebvre, V., Huang, W., Harley, V. R., Goodfellow, P. N. and de Crombrugghe, B. (1997). SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol. Cell. Biol. 17, 2336-2346.
43. Li, H. and Durbin, R. (2009). Fast and accurate short read alignment with Burrows- Wheeler transform. Bioinformatics 25, 1754-1760.
44. Lincoln, J., Lange, A. W. and Yutzey, K. E. (2006). Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. Dev. Biol. 294, 292-302.
45. Lincoln, J., Kist, R., Scherer, G. and Yutzey, K. E. (2007). Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development. Dev. Biol. 305, 120-132.
46. Liu, C.-F. and Lefebvre, V. (2015). The transcription factors SOX9 and SOX5/SOX6 cooperate genome-wide through super-enhancers to drive chondrogenesis. Nucleic Acids Res. 43, 8183-8203.
47. Liu, C., Liu, W., Palie, J., Lu, M. F., Brown, N. A. and Martin, J. F. (2002). Pitx2c patterns anterior myocardium and aortic arch vessels and is required for local cell movement into atrioventricular cushions. Development 129, 5081-5091.
48. Liu, T., Ortiz, J. A., Taing, L., Meyer, C. A., Lee, B., Zhang, Y., Shin, H., Wong, S. S., Ma, J., Lei, Y. et al. (2011). Cistrome: an integrative platform for transcriptional regulation studies. Genome Biol. 12, R83.
49. McAninch, D. and Thomas, P. (2014). Identification of highly conserved putative developmental enhancers bound by SOX3 in neural progenitors using ChIP-Seq. PLoS ONE 9, e113361.
50. Montero, J. A., Giron, B., Arrechedera, H., Cheng, Y.-C., Scotting, P., Chimal- Monroy, J., Garcia-Porrero, J. A. and Hurle, J. M. (2002). Expression of Sox8, Sox9 and Sox10 in the developing valves and autonomic nerves of the embryonic heart. Mech. Dev. 118, 199-202.
51. Nagy, A., Kenesi, E., Rentsendorj, O., Molnar, A., Szenasi, T., Sinko, I., Zvara, A., Oommen, S. T., Barta, E., Puskas, L. G. et al. (2011). Evolutionarily conserved, growth plate zone-specific regulation of the matrilin-1 promoter: L-Sox5/Sox6 and Nfi factors bound near TATA finely tune activation by Sox9. Mol. Cell. Biol. 31, 686-699.
52. Ohba, S., He, X., Hojo, H. and McMahon, A. P. (2015). Distinct transcriptional programs underlie Sox9 regulation of the mammalian chondrocyte. Cell Rep. 12, 229-243.
53. Person, A. D., Klewer, S. E. and Runyan, R. B. (2005). Cell biology of cardiac cushion development. Int. Rev. Cytol. 243, 287-335.
54. Pritchett, J., Athwal, V., Roberts, N., Hanley, N. A. and Hanley, K. P. (2011). Understanding the role of SOX9 in acquired diseases: lessons from development. Trends Mol. Med. 17, 166-174.
55. Robertson, A. G., Bilenky, M., Tam, A., Zhao, Y., Zeng, T., Thiessen, N., Cezard, T., Fejes, A. P., Wederell, E. D., Cullum, R. et al. (2008). Genome-wide relationship between histone H3 lysine 4 mono- and tri-methylation and transcription factor binding. Genome Res. 18, 1906-1917.
56. Robinson, M. D., McCarthy, D. J. and Smyth, G. K. (2010). edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140.
57. Rockich, B. E., Hrycaj, S. M., Shih, H. P., Nagy, M. S., Ferguson, M. A. H., Kopp, J. L., Sander, M., Wellik, D. M. and Spence, J. R. (2013). Sox9 plays multiple roles in the lung epithelium during branching morphogenesis. Proc. Natl. Acad. Sci. USA 110, E4456-E4464.
58. Sekiya, I., Tsuji, K., Koopman, P., Watanabe, H., Yamada, Y., Shinomiya, K., Nifuji, A. and Noda, M. (2000). SOX9 enhances aggrecan gene promoter/ enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J. Biol. Chem. 275, 10738-10744.
59. Shaulian, E. (2010). AP-1-The Jun proteins: oncogenes or tumor suppressors in disguise? Cell. Signal. 22, 894-899.
60. Shelton, E. L. and Yutzey, K. E. (2008). Twist1 function in endocardial cushion cell proliferation, migration, and differentiation during heart valve development. Dev. Biol. 317, 282-295.
61. Shi, Z., Chiang, C.-I., Labhart, P., Zhao, Y., Yang, J., Mistretta, T.-A., Henning, S. J., Maity, S. N. and Mori-Akiyama, Y. (2015). Context-specific role of SOX9 in NF-Y mediated gene regulation in colorectal cancer cells. Nucleic Acids Res. 43, 6257-6269.
62. Snarr, B. S., Kern, C. B. and Wessels, A. (2008). Origin and fate of cardiac mesenchyme. Dev. Dyn. 237, 2804-2819.
63. Stockl, S., Bauer, R. J., Bosserhoff, A. K., Gottl, C., Grifka, J. and Grassel, S. (2013). Sox9 modulates cell survival and adipogenic differentiation of multipotent adult rat mesenchymal stem cells. J. Cell Sci. 126, 2890-2902.
64. Stork, P. J. S. and Schmitt, J. M. (2002). Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 12, 258-266.
65. Timmerman, L. A., Grego-Bessa, J., Raya, A., Bertrán, E., Pérez-Pomares, J. M., Díez, J., Aranda, S., Palomo, S., McCormick, F., Izpisúa-Belmonte, J. C. et al. (2004). Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 18, 99-115.
66. Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J. and Pachter, L. (2010). Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511-515.
67. Trowe, M.-O., Shah, S., Petry, M., Airik, R., Schuster-Gossler, K., Kist, R. and Kispert, A. (2010). Loss of Sox9 in the periotic mesenchyme affects mesenchymal expansion and differentiation, and epithelial morphogenesis during cochlea development in the mouse. Dev. Biol. 342, 51-62.
68. Vincentz, J. W., Barnes, R. M., Rodgers, R., Firulli, B. A., Conway, S. J. and Firulli, A. B. (2008). An absence of Twist1 results in aberrant cardiac neural crest morphogenesis. Dev. Biol. 320, 131-139.
69. Vrljicak, P., Cullum, R., Xu, E., Chang, A. C. Y., Wederell, E. D., Bilenky, M., Jones, S. J. M., Marra, M. A., Karsan, A. and Hoodless, P. A. (2012). Twist1 transcriptional targets in the developing atrio-ventricular canal of the mouse. PLoS ONE 7, e40815.
70. Wagner, T., Wirth, J., Meyer, J., Zabel, B., Held, M., Zimmer, J., Pasantes, J., Bricarelli, F. D., Keutel, J., Hustert, E. et al. (1994). Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79, 1111-1120.
71. Wheatley, S.,Wright, E., Jeske, Y., Mccormack, A., Bowles, J. and Koopman, P. (1996). Aetiology of the skeletal dysmorphology syndrome campomelic dysplasia: expression of the Sox9 gene during chondrogenesis in mouse embryos. Ann. N. Y. Acad. Sci. 785, 350-352.
72. Xu, N., Lao, Y., Zhang, Y. and Gillespie, D. A. (2012). Akt: a double-edged sword in cell proliferation and genome stability. J. Oncol. 2012, 951724.
73. Ya, J., Schilham, M. W., de Boer, P. A., Moorman, A. F. M., Clevers, H. and Lamers, W. H. (1998). Sox4-deficiency syndrome in mice is an animal model for common trunk. Circ. Res. 83, 986-994.